Associação Beneficente de Coleta de Sangue, Av. Jandira 1260, São Paulo, SP, Brazil.
Braz J Infect Dis. 2010 Mar-Apr;14(2):147-52. doi: 10.1590/s1413-86702010000200006.
Polymerase chain reaction (PCR) methods play an essential role in providing data related to diagnosis, monitoring and treatment of hepatitis C virus (HCV) infection. EIA results are reported as ''reactive'' or ''non reactive'' and EIA S/CO ratio may also be reported as ''high'' or ''low.'' This study aimed to evaluate the performance of a real-time RT-PCR and assess whether there is relationship between S/CO and PCR results.
Sera from blood donors were analyzed by Enzyme-Linked Immunosorbent Assay (ELISA) and RT-PCR assay to detect HCV infection.
The RT-PCR assay to genotypes 1a/b showed an acceptable linear response in serial dilutions. The samples were divided into two groups based on their serological results: group A--S/CO ratio < 3 (60 samples) and group B--S/CO ratio > 3 (41 samples). Viral loads were confirmed positive in group B samples in 90%, and in group A samples were confirmed positive in only 13% by RT-PCR.
The methodology used was able to detect the presence of RNA-HCV genotype I in 90% of the samples serologically positive in group B. All negative samples were sent to search for other genotypes of HCV (genotypes 2-6) and were confirmed as negative. These data suggests that these negative samples may have HCV RNA viral load below the detection limit of our test (310 IU/ mL), or a false positive result in serological test, or spontaneous viral clearance occurred.
聚合酶链反应(PCR)方法在提供与丙型肝炎病毒(HCV)感染的诊断、监测和治疗相关的数据方面发挥着重要作用。酶联免疫吸附试验(ELISA)结果报告为“反应性”或“非反应性”,EIA S/CO 比值也可能报告为“高”或“低”。本研究旨在评估实时 RT-PCR 的性能,并评估 S/CO 与 PCR 结果之间是否存在关系。
通过酶联免疫吸附试验(ELISA)和 RT-PCR 检测献血者血清,以检测 HCV 感染。
用于检测基因型 1a/b 的 RT-PCR 分析在系列稀释中表现出可接受的线性响应。根据血清学结果将样本分为两组:A 组-S/CO 比值<3(60 份样本)和 B 组-S/CO 比值>3(41 份样本)。B 组样本的病毒载量通过 RT-PCR 证实阳性率为 90%,而 A 组样本的病毒载量通过 RT-PCR 证实阳性率仅为 13%。
所使用的方法能够检测到 B 组血清学阳性样本中 90%存在 RNA-HCV 基因型 I。所有阴性样本均被送去寻找其他 HCV 基因型(基因型 2-6),并被证实为阴性。这些数据表明,这些阴性样本可能具有低于我们检测限(310 IU/mL)的 HCV RNA 病毒载量,或者在血清学检测中出现假阳性结果,或者自发的病毒清除。